Has Manuela Schuksz, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,620 in general payments to Manuela Schuksz, MD across 114 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Manuela Schuksz, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Manuela Schuksz, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Manuela Schuksz, MD

Vascular Surgery · Colonial Heights, VANPI 1770879207

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,987 of the $5,620 with a category attached, or 88.7%. 19 manufacturers reported payments, led by Medtronic at 43.0% of the total. Reporting peaked in 2019 at $1,434 and has fallen 58.2% since, to $600 in 2025. That places this record below the midpoint for vascular surgery clinicians in VA, where the typical reported total is $4,916.

$5,620in general payments, 2019–2025

Across 114 payments — averaging $49.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$2K
W. L. Gore & Associates, Inc.$664
Silk Road Medical, Inc.$459
Tactile Systems Technology Inc$452
Johnson & Johnson$398
Boston Scientific$338
plus $893 from 13 others

What the payments were for

Travel & lodging$63311%
Food & beverage$4,98789%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	38	$2,416
W. L. Gore & Associates, Inc.	7	$664
Silk Road Medical, Inc.	7	$459
Tactile Systems Technology Inc	10	$452
Johnson & Johnson	10	$398
Boston Scientific	8	$338
Mimedx Group, Inc.	14	$312
Bard Peripheral Vascular, Inc.	3	$108
Philips North America LLC	2	$95
Cook Medical LLC	3	$81
Smith+Nephew	3	$73
Inari Medical, Inc.	1	$47
Amgen	2	$44
Solventum Corporation	1	$42
Integra Lifesciences Corporation	1	$23
Organogenesis Inc.	1	$20
Penumbra, Inc.	1	$19
Pfizer	1	$16
E.r. Squibb & Sons, L.L.C.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Abre$598
ENDURANT IIS$331
TurboHawk$303
C3 Delivery System$278
Flexitouch Plus$277
Nimbl$277
ENROUTE Transcarotid Neuroprotection System$260
ENROUTE Transcarotid Stent$260
XARELTO$241
ENHANCE Transcarotid Peripheral Access Kit$154
ENROUTE .014 Guidewire$154
HawkOne$143
Varithena Administration Pack$143
VenaSeal$138
TIGRIS Stent$134
IN.PACT Admiral$104

How this compares

$5,620 in reported general payments places this provider in the 50th percentile of 143 vascular surgery providers in Virginia.

See all vascular surgery providers in Virginia →

Medicare billing

Part B allowed, 2024

$269,962

Medicare patients

535

Services billed

1,449

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gentamicin Sulfate	19	$978
Tramadol Hcl	26	$71
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	12	$55
Cephalexin	11	$47
Lorazepam	25	$42
Diazepam	19	$21

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Colonial Heights

Jean PannetonVirginia Beach$1.3M
John DeitrickRichmond$684K
Rasesh ShahChesapeake$465K
David DexterNorfolk$404K
Samuel SteermanVirginia Beach$252K
Joseph BabrowiczFairfax$202K
Joshua AdamsRoanoke$138K
Richard NevilleFalls Church$114K
Anthony ComerotaFalls Church$107K
Animesh RathoreNorfolk$83K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →